NATICK, Mass., June 7 /PRNewswire/ -- Intact Medical Corporation, an emerging leader in the development and marketing of minimally invasive systems for the diagnosis of breast cancer, today announced that the use of the Intact Breast Lesion Excision System (BLES) to biopsy high-risk breast lesions for histopathological analysis, or those lesions which are subsequently diagnosed as cancerous, can qualify for a higher level of reimbursement under CPT Code 88307. The average Medicare reimbursement (physicians) rate for this code is $184.56, a 78% increase over CPT 88305 - routinely used for vacuum-assisted core needle procedures. The average Medicare reimbursement (physicians) rate for 88305 is $103.46.
